Condition
Biochemically Recurrent Prostate Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Biochemically Recurrent Prostate Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (5), Spain (1)). By phase: Phase 2 (3), Phase 3 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Biochemically Recurrent Prostate Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer | — | Benidorm, Alicante and 9 other locations | Recruiting | Oct 6, 2026 |
| Home versus clinic cancer treatment for Black men with advanced or recurrent prostate cancer | Phase 2 | Jacksonville, Florida | Recruiting | Jul 18, 2025 |
| Investigational scan for detecting recurrent prostate cancer | Early Phase 1 | Chicago, Illinois | Recruiting | Feb 7, 2025 |
| Combining radiation therapy with hormone treatments for advanced prostate cancer | Phase 2 | Phoenix, Arizona and 2 other locations | Recruiting | Apr 23, 2024 |
| Exercise and Fitbit monitoring for prostate cancer patients on hormone therapy | Phase 2 | Houston, Texas | Recruiting | Sep 23, 2021 |
| Combining Apalutamide and Targeted Radiation for Recurrent Prostate Cancer | Phase 3 | Anchorage, Alaska and 340 other locations | Recruiting | Jun 9, 2020 |
All recruiting trials (6)
-
Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer
This observational study tests whether salvage HDR brachytherapy can help men with locally recurrent prostate cancer after initial radiotherapy, using advanced imaging and biopsy to guide treatment.
-
Home versus clinic cancer treatment for Black men with advanced or recurrent prostate cancer
This Phase II test tries whether giving cancer treatments at home instead of in the clinic is safer and more satisfying for Black men with locally advanced, biochemically recurrent, or metastatic prostate cancer.
-
Investigational scan for detecting recurrent prostate cancer
This study is testing a new imaging technique to see if it can help find prostate cancer in men whose PSA levels are rising after treatment but who had a negative result on their last scan.
-
Combining radiation therapy with hormone treatments for advanced prostate cancer
This study is testing if combining a specific type of radiation therapy with hormone treatments can help men with advanced prostate cancer live longer and feel better compared to just using radiation alone.
-
Exercise and Fitbit monitoring for prostate cancer patients on hormone therapy
This study tests if a 16-week exercise program with Fitbit tracking can help prostate cancer patients on hormone therapy improve their heart health and manage other related health risks.
-
Combining Apalutamide and Targeted Radiation for Recurrent Prostate Cancer
This study is testing if combining a new medication with radiation therapy can help men with recurring prostate cancer feel better and live longer after surgery.
Related topics
Quick answers
How many Biochemically Recurrent Prostate Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.